Atlas Trials

5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer

Clinical trial NCT06887218 · RECRUITING

Trial details

NCT number
NCT06887218
Sponsor
The Methodist Hospital Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer (CRC)
Start date
2025-05-08
Primary completion
2028-12-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.